164 related articles for article (PubMed ID: 17209045)
1. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.
Plaza-Menacho I; van der Sluis T; Hollema H; Gimm O; Buys CH; Magee AI; Isacke CM; Hofstra RM; Eggen BJ
J Biol Chem; 2007 Mar; 282(9):6415-24. PubMed ID: 17209045
[TBL] [Abstract][Full Text] [Related]
2. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM
Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368
[TBL] [Abstract][Full Text] [Related]
3. In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp.
Prazeres H; Couto JP; Rodrigues F; Vinagre J; Torres J; Trovisco V; Martins TC; Sobrinho-Simões M; Soares P
Endocr Relat Cancer; 2011 Aug; 18(4):401-12. PubMed ID: 21551259
[TBL] [Abstract][Full Text] [Related]
4. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
Colombo C; Minna E; Rizzetti MG; Romeo P; Lecis D; Persani L; Mondellini P; Pierotti MA; Greco A; Fugazzola L; Borrello MG
Orphanet J Rare Dis; 2015 Mar; 10():25. PubMed ID: 25887804
[TBL] [Abstract][Full Text] [Related]
5. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
[TBL] [Abstract][Full Text] [Related]
6. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.
Yue CH; Oner M; Chiu CY; Chen MC; Teng CL; Wang HY; Hsieh JT; Lai CH; Lin H
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207842
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
10. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.
Turkson J; Bowman T; Adnane J; Zhang Y; Djeu JY; Sekharam M; Frank DA; Holzman LB; Wu J; Sebti S; Jove R
Mol Cell Biol; 1999 Nov; 19(11):7519-28. PubMed ID: 10523640
[TBL] [Abstract][Full Text] [Related]
11. Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.
Iwashita T; Kato M; Murakami H; Asai N; Ishiguro Y; Ito S; Iwata Y; Kawai K; Asai M; Kurokawa K; Kajita H; Takahashi M
Oncogene; 1999 Jul; 18(26):3919-22. PubMed ID: 10445857
[TBL] [Abstract][Full Text] [Related]
12. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
13. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
15. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
16. MEN2A-RET-induced cellular transformation by activation of STAT3.
Schuringa JJ; Wojtachnio K; Hagens W; Vellenga E; Buys CH; Hofstra R; Kruijer W
Oncogene; 2001 Aug; 20(38):5350-8. PubMed ID: 11536047
[TBL] [Abstract][Full Text] [Related]
17. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
18. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
Turkson J; Bowman T; Garcia R; Caldenhoven E; De Groot RP; Jove R
Mol Cell Biol; 1998 May; 18(5):2545-52. PubMed ID: 9566874
[TBL] [Abstract][Full Text] [Related]
19. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
Lo RK; Cheung H; Wong YH
J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
